Your browser doesn't support javascript.
loading
Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer.
Rebattu, P; Quantin, X; Ardiet, C; Morere, J F; Azarian, M R; Schuller-Lebeau, M P; Pujol, J L.
Affiliation
  • Rebattu P; Cancer Institute Centre Léon Bérard 28, rue Laënnec, 69373 Lyon, Cedex, France. rebattu@lyon.fnclcc.fr
Lung Cancer ; 33(2-3): 277-87, 2001.
Article in En | MEDLINE | ID: mdl-11551423
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Taxoids / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2001 Type: Article Affiliation country: France
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Taxoids / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2001 Type: Article Affiliation country: France